Results 151 to 160 of about 15,524,849 (357)
Diana E Yung,1 John N Plevris,1 Romain Leenhardt,2 Xavier Dray,2 Anastasios Koulaouzidis1 On behalf of the ESGE Small Bowel Research Working Group1Centre for Liver and Digestive Disorders, The Royal Infirmary of Edinburgh, Edinburgh, UK; 2Sorbonne ...
Yung DE +4 more
doaj
New advances in the Clinica software platform for clinical neuroimaging studies
A. Routier +13 more
semanticscholar +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.
K. Tamura +3 more
semanticscholar +1 more source
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source

